PMCB
PMCB
NASDAQ · Biotechnology

Pharmacyte Biotech Inc

$0.74
+0.04 (+5.89%)
As of Feb 8, 2:30 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 1.57M 1.60M 1.25M
Net Income 4.2K 5.8K 3.4K
EPS
Profit Margin 0.3% 0.4% 0.3%
Rev Growth -8.5% +15.0% -6.0%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 3.28M 2.87M 3.13M
Total Equity 3.56M 3.27M 3.26M
D/E Ratio 0.92 0.88 0.96
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 8.2K 8.5K 6.5K
Free Cash Flow 4.7K 4.2K 2.8K